Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells

World Journal of Gastroenterology

Volumn 19, Issue 10, 2013, Pages 1582-1592

  Tang, Xi Ping ^a   Tang, Guo Du ^a   Fang, Chun Yun ^a   Liang, Zhi Hai ^a   Zhang, Lu Yi ^a  

^a GUANGXI MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Ginsenoside rh2; Human pancreatic cancer bxpc 3 cell; Migration; Proliferation

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL) [2, 5' BI 1H BENZIMIDAZOL] 2' YL] PHENOL; CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN D1; GELATINASE A; GELATINASE B; GINSENOSIDE RH 2; MESSENGER RNA; PROTEIN BAX; PROTEIN BCL 2; SURVIVIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER GROWTH; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CLONOGENIC ASSAY; COLONY FORMATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; PANCREAS CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; WOUND HEALING;

EID: 84875342419     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i10.1582     Document Type: Article

References (31)

1. Goldstein D, Carroll S, Apte M, Keogh G. Modern management of pancreatic carcinoma. Intern Med J 2004; 34: 475-481 [PMID: 15317546 DOI: 10.1111/j.1444-0903.2004.00658.x]
2. Ma SW, Benzie IF, Chu TT, Fok BS, Tomlinson B, Critchley LA. Effect of Panax ginseng supplementation on biomarkers of glucose tolerance, antioxidant status and oxidative stress in type 2 diabetic subjects: results of a placebo-controlled human intervention trial. Diabetes Obes Metab 2008; 10: 1125-1127 [PMID: 18355331 DOI: 10.1111/j.1463-1326.2008. 00858.x]
3. Ang-Lee MK, Moss J, Yuan CS. Herbal medicines and perioperative care. JAMA 2001; 286: 208-216 [PMID: 11448284 DOI: 10.1001/jama.286.2.208]
4. Xie JT, Mchendale S, Yuan CS. Ginseng and diabetes. Am J Chin Med 2005; 33: 397-404 [PMID: 16047557 DOI: 10.1142/ S0192415X05003004]
5. Wang CZ, Yuan CS. Potential role of ginseng in the treatment of colorectal cancer. Am J Chin Med 2008; 36: 1019-1028 [PMID: 19051332 DOI: 10.1142/S0192415X08006545]
6. Wang CZ, Aung HH, Ni M, Wu JA, Tong R, Wicks S, He TC, Yuan CS. Red American ginseng: ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots. Planta Med 2007; 73: 669-674 [PMID: 17538869 DOI: 10.1055/s-2007-981524]
7. Luo X, Wang CZ, Chen J, Song WX, Luo J, Tang N, He BC, Kang Q, Wang Y, Du W, He TC, Yuan CS. Characterization of gene expression regulated by American ginseng and ginsenoside Rg3 in human colorectal cancer cells. Int J Oncol 2008; 32: 975-983 [PMID: 18425323]
8. Oh M, Choi YH, Choi S, Chung H, Kim K, Kim SI, Kim DK, Kim ND. Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells. Int J Oncol 1999; 14: 869-875 [PMID: 10200336]
9. Choi S, Oh JY, Kim SJ. Ginsenoside Rh2 induces Bcl-2 family proteins-mediated apoptosis in vitro and in xenografts in vivo models. J Cell Biochem 2011; 112: 330-340 [PMID: 21080338 DOI: 10.1002/jcb.22932]
10. Kim HS, Lee EH, Ko SR, Choi KJ, Park JH, Im DS. Effects of ginsenosides Rg3 and Rh2 on the proliferation of prostate cancer cells. Arch Pharm Res 2004; 27: 429-435 [PMID: 15180309 DOI: 10.1007/BF02980085]
11. Wu XZ, Xie GR. Induced differentiation of hepatocellular carcinoma by natural products. Afr J Tradit Complement Altern Med 2008; 5: 325-331 [PMID: 20161953]
12. Qu X, Qu S, Yu X, Xu H, Chen Y, Ma X, Sui D. pseudo-G-Rh2 induces mitochondrial-mediated apoptosis in SGC-7901 human gastric cancer cells. Oncol Rep 2011; 26: 1441-1446 [PMID: 21887470 DOI: 10.3892/or.2011.1442]
13. Wang CZ, Li XL, Wang QF, Mehendale SR, Fishbein AB, Han AH, Sun S, Yuan CS. The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cells. Oncol Rep 2009; 21: 577-584 [PMID: 19212614]
14. Yue PY, Mak NK, Cheng YK, Leung KW, Ng TB, Fan DT, Yeung HW, Wong RN. Pharmacogenomics and the Yin/ Yang actions of ginseng: anti-tumor, angiomodulating and steroid-like activities of ginsenosides. Chin Med 2007; 2: 6 [PMID: 17502003 DOI: 10.1186/1749-8546-2-6]
15. Choi S, Kim TW, Singh SV. Ginsenoside Rh2-mediated G1 phase cell cycle arrest in human breast cancer cells is caused by p15 Ink4B and p27 Kip1-dependent inhibition of cyclindependent kinases. Pharm Res 2009; 26: 2280-2288 [PMID: 19629651 DOI: 10.1007/s11095-009-9944-9]
16. Li B, Zhao J, Wang CZ, Searle J, He TC, Yuan CS, Du W. Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer Lett 2011; 301: 185-192 [PMID: 21194832 DOI: 10.1016/ j.canlet.2010.11.015]
17. Hahm ER, Arlotti JA, Marynowski SW, Singh SV. Honokiol, a constituent of oriental medicinal herb magnolia officinalis, inhibits growth of PC-3 xenografts in vivo in association with apoptosis induction. Clin Cancer Res 2008; 14: 1248-1257 [PMID: 18281560]
18. Han MH, Yoo YH, Choi YH. Sanguinarine-induced apoptosis in human leukemia U937 cells via Bcl-2 downregulation and caspase-3 activation. Chemotherapy 2008; 54: 157-165 [PMID: 18560221 DOI: 10.1159/000140359]
19. Hong SJ, Dawson TM, Dawson VL. Nuclear and mitochondrial conversations in cell death: PARP-1 and AIF signaling. Trends Pharmacol Sci 2004; 25: 259-264 [PMID: 15120492 DOI: 10.1016/j.tips.2004.03.005]
20. Altieri DC. Survivin and IAP proteins in cell-death mechanisms. Biochem J 2010; 430: 199-205 [PMID: 20704571 DOI: 10.1042/BJ20100814]
21. Zhang R, Ma L, Zheng M, Ren J, Wang T, Meng Y, Zhao J, Jia L, Yao L, Han H, Li K, Yang A. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice. Cancer Gene Ther 2010; 17: 275-288 [PMID: 19876077 DOI: 10.1038/ cgt.2009.68]
22. Altieri DC. Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 2003; 22: 8581-8589 [PMID: 14634620 DOI: 10.1038/sj.onc.1207113]
23. Augello C, Caruso L, Maggioni M, Donadon M, Montorsi M, Santambrogio R, Torzilli G, Vaira V, Pellegrini C, Roncalli M, Coggi G, Bosari S. Inhibitors of apoptosis proteins (IAPs) expression and their prognostic significance in hepatocellular carcinoma. BMC Cancer 2009; 9: 125 [PMID: 19397802 DOI: 10.1186/1471-2407-9-125]
24. Khanna A, Mahalingam K, Chakrabarti D, Periyasamy G. Ets-1 expression and gemcitabine chemoresistance in pancreatic cancer cells. Cell Mol Biol Lett 2011; 16: 101-113 [PMID: 21225469 DOI: 10.2478/s11658-010-0043-z]
25. Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, Shriver CD. Circulating MMP2 and MMP9 in breast cancer-potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer 2006; 119: 1403-1411 [PMID: 16615109 DOI: 10.1002/ijc.21989]
26. Stahtea XN, Roussidis AE, Kanakis I, Tzanakakis GN, Chalkiadakis G, Mavroudis D, Kletsas D, Karamanos NK. Imatinib inhibits colorectal cancer cell growth and suppresses stromal-induced growth stimulation, MT1-MMP expression and pro-MMP2 activation. Int J Cancer 2007; 121: 2808-2814 [PMID: 17721919 DOI: 10.1002/ijc.23029]
27. Yamamoto H, Vinitketkumnuen A, Adachi Y, Taniguchi H, Hirata T, Miyamoto N, Nosho K, Imsumran A, Fujita M, Hosokawa M, Hinoda Y, Imai K. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. Carcinogenesis 2004; 25: 2353-2360[PMID: 15333466 DOI: 10.1093/carcin/bgh270]
28. Wang L, Zhang LH, Li YL, Li YL, Liu Z. [Expression of MMP-9 and MMP-9 mRNA in gastric carcinoma and its correlation with angiogenesis]. Zhonghua Yixue Zazhi 2003; 83: 782-786 [PMID: 12899759]
29. Zhang S, Li L, Lin JY, Lin H. Imbalance between expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase- 1 in invasiveness and metastasis of human gastric carcinoma. World J Gastroenterol 2003; 9: 899-904 [PMID: 12717827]
30. Tutton MG, George ML, Eccles SA, Burton S, Swift RI, Abulafi AM. Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients. Int J Cancer 2003; 107: 541-550 [PMID: 14520690 DOI: 10.1002/ ijc.11436]
31. Bloomston M, Zervos EE, Rosemurgy AS. Matrix metalloproteinases and their role in pancreatic cancer: a review of preclinical studies and clinical trials. Ann Surg Oncol 2002; 9: 668-674 [PMID: 12167581 DOI: 10.1007/BF02574483]